Medlab still in limbo as talks continue with ‘interested parties’ by Steve Jones June 7, 2023April 30, 2024 The future of Medlab Clinical remains uncertain as the company continues to explore restructuring options. Shareholders […]
Scrutiny of SAS-B data for psychiatric conditions exposes prescribing ‘disconnect’ by Steve Jones June 7, 2023April 30, 2024
Montu caught in second product dispute over ‘out of stock’ claims by Steve Jones June 7, 2023April 30, 2024
Creso Pharma eyes Australian market as firm seeks GMP licence by Steve Jones June 6, 2023April 30, 2024
‘It all starts with flower’: Tasmanian Botanics takes local road to long-term success by Steve Jones June 5, 2023April 30, 2024
Lennox-Gastaut syndrome becomes second Epidyolex indication to be listed on PBS by Steve Jones June 5, 2023April 30, 2024
Creditors advised to wind up BBS Pharmaceuticals as investigations continue into firm’s financial affairs by Steve Jones June 1, 2023April 30, 2024
Overseas manufacturers in bid to supply non-compliant product for ‘limited period’ beyond July 1 by Steve Jones May 31, 2023April 30, 2024
Bod Science to test drug-delivery tech on psychiatric medication by Steve Jones May 31, 2023April 30, 2024
NZ study finds cannabis users reduced reliance on opioid medication by Steve Jones May 30, 2023April 30, 2024